tradingkey.logo
tradingkey.logo
Search

GE HealthCare tops Q4 profit estimates, offers full-year guidance

Investing.comFeb 13, 2025 12:00 PM
facebooktwitterlinkedin
View all comments(0)

GE HealthCare Technologies Inc (NASDAQ:GEHC) posted better-than-expected earnings and adjusted EBIT for the fourth quarter, while revenue marginally missed expectations.

The health technology company reported Q4 earnings per share (EPS) of $1.45, surpassing consensus estimates of $1.26. The company's revenue rose 2% year-over-year to $5.32 billion, nearly in line with the expected $5.33 billion.

Adjusted EBIT rose 19% year-on-year to $994 million, ahead of the $905.9 million forecast.

“We were pleased with the strong momentum in orders, backlog and book-to-bill that we saw in the fourth quarter. We also continued to deliver revenue growth driven by demand in our Advanced Visualization Solutions and Pharmaceutical (TADAWUL:2070) Diagnostics businesses, with overall strength in the U.S., and robust margin expansion and earnings growth," said GE HealthCare President and CEO Peter Arduini.

"Customer interest in new, differentiated products contributed to orders growth and recurring revenue in the year. We remain committed to our precision care strategy for growth, supported by innovation, productivity initiatives, and commercial execution.”

For fiscal 2025, GE HealthCare expects EPS between $4.61 and $4.75, compared to the consensus estimate of $4.65.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.